Pancreatic Adenocarcinoma Gene Environment Risk Study

Description

After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

Conditions

Pancreatic Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

The Pancreatic Adenocarcinoma Gene Environment Risk Study -A Prospective Cohort Study of Patients at Risk or Having Pancreatic Disease

Pancreatic Adenocarcinoma Gene Environment Risk Study

Condition
Pancreatic Cancer
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

University of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma
  • * Subjects with abnormal imaging study (CT, MRI, MRCP, EUS)
  • * Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition
  • * Control subject with acute pancreatitis
  • * Control subject with chronic pancreatitis
  • * Control subject with biliary obstruction
  • * Control subject with pancreatic cyst
  • * Member of a high risk family (≥ 1 close relative with pancreatic cancer)
  • * Healthy control (without any of the above conditions)
  • * Under the age of 18 years
  • * Unable to give informed consent
  • * Inability to travel to Pittsburgh for in-person enrollment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Pittsburgh,

Randall E Brand, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

2027-12